Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: A quality improvement study

Internal Medicine Journal

Volumn 43, Issue 7, 2013, Pages 772-777

  Kennedy, N A ^a,b   Rodgers, A ^a   Altus, R ^a   Mccormick, R ^a   Wundke, R ^a   Wigg, A J ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Alphafetoprotein; Cirrhosis; Hepatitis C; Hepatocellular carcinoma; Ultrasound

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SCREENING; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL EDUCATION; PATIENT EDUCATION; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT; VIRUS HEPATITIS;

ALPHAFETOPROTEIN; CIRRHOSIS; HEPATITIS C; HEPATOCELLULAR CARCINOMA; ULTRASOUND;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER NEOPLASMS; MALE; MEDICAL AUDIT; MIDDLE AGED; POPULATION SURVEILLANCE; QUALITY IMPROVEMENT;

EID: 84880354374     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12166     Document Type: Article

References (21)

1. International Agency for Research on Cancer. Globocan 2008. [homepage on the Internet]. [updated 2010; cited 2012 Nov 25]. Available from URL: http://globocan.iarc.fr/.
2. Australian Bureau of Statistics. Causes of Death 2009. [homepage on the Internet]. [updated 2011; cited 2012 Nov 25]. Available from URL: http://www.abs.gov.au/ausstats/abs@.nsf/mf/3303.0.
3. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. Journal of Hepatology 2002; 37: 806-813.
4. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
5. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
6. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52-(Suppl 3): iii1-8.
7. Zhang B-H, Yang B-H, Tang Z-Y. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417-422.
8. Qian MYY, Yuwei JR, Angus P, Schelleman T, Johnson L, Gow P. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. J Gastroenterol Hepatol 2010; 25: 951-956.
9. Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M etal. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess 2007; 11: 1-206.
10. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 2010; 52: 132-141.
11. Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z etal. Utilisation of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med 2011; 154: 85-93.
12. McCulloch P, Kreckler S, New S, Sheena Y, Handa A, Catchpole K. Effect of a 'Lean' intervention to improve safety processes and outcomes on a surgical emergency unit. BMJ 2010; 341: c5469.
13. Wilson RM, Harrison BT. What is clinical practice improvement? Intern Med J 2002; 32: 460-464.
14. Wundke R, Altus R, Sandford J, Wigg A. Improving management of oesophageal varices in patients with cirrhosis. Quality & Safety in Health Care 2010; 19: 536-541.
15. El-Serag HB, Talwalkar J, Kim WR. Efficacy, effectiveness, and comparative effectiveness in liver disease. Hepatology 2010; 52: 403-407.
16. Kollef MH. Clinical practice improvement initiatives: don't be satisfied with the early results. Chest 2009; 136: 335-338.
17. Wong GL-H, Wong VW-S, Tan G-M, Ip K-I, Lai W-K, Li Y-W etal. Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int 2008; 28: 79-87.
18. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R etal. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-1014.
19. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G etal. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251-259.
20. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. The Milbank Quarterly 1996; 74: 511-544.
21. El-Serag HB, Kramer JR, Chen GJ, Duan Z, Richardson PA, Davila JA. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut 2011; 60: 992-997.